Get Started
Customer Resources
LivingConnected® Clinical Solution
LivingConnected® Clinical Solution
For Partners
Reorder

Tandem Mobi System

Discover the Tandem Mobi system, the world’s smallest, durable automated insulin delivery system1.

Specifications

  • Automated Insulin Delivery: Control-IQ technology that predicts and helps prevent highs and lows when paired with a compatible CGM
  • Mobile Control: Controllable with compatible, personal iPhone†
  • Multi-CGM Integration: Compatible with Dexcom G6 CGM sensor* (Dexcom G7 expected Q2, 2024)
  • Wireless Data Uploads & Software Updates: Access to personal therapy data (once per hour) and future software updates wirelessly
  • Enhanced Wearability: Impressively small, it can be worn on-body with an easy-to-use adhesive sleeve (sold separately), clipped on clothing, or comfortably slipped into a coin pocket.
  • IP28 Water-Resistant: Tested at 8 ft. for up to 2 hours
  • Flexible Pump Button: Deliver quick bolus in units or carbs, LED status indicator
  • Wireless Charging: Comes with a wireless charging pad

1 As of Feb., 2024. Data on file, Tandem Diabetes Care.

* CGM sold separately. Integration with Dexcom G7 is under development. The safety and effectiveness of Dexcom G7 with Tandem Mobi has not yet been established. Tandem Mobi is intended for use with Dexcom G6 CGM.

† The mobile apps require a compatible smartphone model and operating system (sold separately). Only available to pump users who reside in the USA.

‡ Future updates for all or some Tandem products may not be developed and may not be offered everywhere and would be subject to applicable regulatory approvals. Software updates are only available to customers who are in warranty at the time they update their pump. Additional training may be required to access certain software updates. Charges may apply. Tandem may discontinue select software and features over time at its discretion.

§Tested at 8 feet for 2 hours (IP28 rating).

 

See More

Description

Important Safety Information

RX ONLY.

Indications for Use

Tandem Mobi system: The Tandem Mobi insulin pump with interoperable technology (the pump) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is intended for single patient, home use and requires a prescription. The pump is indicated for use in individuals 6 years of age and greater.

Control-IQ technology: Control-IQ technology is intended for use with compatible integrated continuous glucose monitors (iCGM, sold separately) and alternate controller enabled (ACE) pumps to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. Control-IQ technology is intended for the management of Type 1 diabetes mellitus in persons 6 years of age and greater. Control-IQ technology is intended for single patient use. Control-IQ technology is indicated for use with NovoLog or Humalog U-100 insulin.

Warning: Control-IQ technology should not be used by anyone under the age of 6 years old. It should also not be used in patients who require less than 10 units of insulin per day or who weigh less than 55 pounds.

Control-IQ technology is not indicated for use in pregnant women, people on dialysis, or critically ill patients. Do not use Control-IQ technology if using hydroxyurea. Users of a Tandem insulin pump and Control-IQ technology must use the insulin pump, CGM, and all other system components in accordance with their respective instructions for use; test blood glucose levels as recommended by their healthcare provider; demonstrate adequate carb-counting skills; maintain sufficient diabetes self-care skills; see healthcare provider(s) regularly; and have adequate vision and/or hearing to recognize all functions of the pump, including alerts, alarms, and reminders. The Tandem pump and the CGM transmitter and sensor must be removed before MRI, CT, or diathermy treatment. Visit tandemdiabetes.com/safetyinfo for additional important safety information.

See More
Back to Catalogue

Frequently Asked Questions

Who is responsible for getting the insurance authorizations for medical supplies?

Does the company provide service and supplies to Medicare and Medicaid patients?

Are you a participating provider with other insurance companies?

Are all products covered by my insurance company?

How much will a patient have to pay for his or her product?

Do I need to apply for Medicare when I turn 65?

Who can receive benefits for diabetes self-management training?

How do I know my diabetes supplies are covered by Medicare?

How much is reimbursed for each product?

Does everyone pay the same amount for the Part B premium?

Are there limits on the quantity of diabetes supplies that Medicare will reimburse?

How do I replace my Medicare card?

If I am 65 and ready to retire and my employer is going to provide me with benefits, do I need Medicare?

Does Medicare cover my spouse and family?

What is the difference between Medicare and Medicaid?

Where should I send my Medicare premium payment?

Who can I contact for more information about Medicare eligibility?